Naizer, Hayden
Kohl III, Harold
Krause, Trudy
Hamden, Randa
Wozny, Joseph
Charron, Odelin
Freeman, Leorah https://orcid.org/0000-0002-5696-1797
Article History
Received: 12 June 2024
Accepted: 2 October 2024
First Online: 12 October 2024
Declarations
:
: This study was reviewed and deemed exempt by the UTHealth CPHS Institutional Review Board because the research data was de-identified.
: Not applicable. Informed consent was not necessary as our data was derived from a de-identified insurance claims database.
: Hayden Naizer, Harold Kohl III, Trudy Millard Krause Randa Hamden, Joseph Wozny, and Odelin Charron have nothing to disclose. Leorah Freeman has received fees for consultancy and/or advisory board participation from Hoffmann-La Roche, Genentech, Novartis, EMD Serono, Sanofi, and Horizon Therapeutics; has received honorarium for participation in educational programs from Medscape, Inc, and the MS Association of America; has received speaking fees from Sanofi, EMD Serono, and the MS Association of America; has received program sponsorship from EMD Serono and grant support from NIH/NINDS, PCORI, Genentech, and EMD Serono through her institution.